Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Product Categories
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
ADX-88178 is a positive allosteric modulator (PAM) of metabotropic glutamate receptor 4 (mGluR4).1 It enhances glutamate-induced intracellular calcium mobilization in HEK293 cells expressing human or rat mGluR4 (EC50s = 3.5 and 9.1 nM, respectively). ADX-88178 is selective for mGluR4 over mGluR1, mGluR2, mGluR3, mGluR5, mGluR7, and the GABAB receptor at 30 µM, mGluR6 at 10 µM, and mGluR8 (EC50 = 2.2 µM). It is also selective for mGluR4 over a panel of 71 receptors, transporters, enzymes, and ion channels at 10 µM. ADX-88178 (10 mg/kg) reverses catalepsy induced by haloperidol (Item No. 12014) in rats. It enhances L-DOPA-induced decreases in motor impairments in 6-OHDA-lesioned rats in a dose-dependent manner. However, it does not reverse L-DOPA- and benserazide-induced dyskinesia in 6-OHDA-lesioned rats.2
WARNING This product is not for human or veterinary use.
1. A potent and selective metabotropic glutamate receptor 4 positive allosteric modulator improves movement in rodent models of Parkinson’s disease. J. Pharmacol. Exp. Ther. 343(1), 167-177 (2012).
2. Metabotropic glutamate receptor 4 (mGlu4) positive allosteric modulators lack efficacy in rat and marmoset models of L-